Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS)

Q: What does CUSIP 23254L876 represent in this 13F holders report?

CUSIP 23254L876 is the security identifier for BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share in Q1 2026?

9 institutional investors reported BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 23254L876

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 5,519,894
Total 13F shares: 118,543
Share change: +39,505
Total reported value: $118,543
Price per share: $1.00
Number of holders: 9
Value change: +$14,141
Number of buys: 7
Number of sells: 3

Security key

23254L876

Report period

Q1 2026

Institutions

Top holders

BGMS full security history Previous quarter: Q4 2025 Bio Green Med Solution, Inc. SEC filings Bio Green Med Solution, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 23254L876

Previous quarter: Q4 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Top shareholders of BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Datuk Dr. Doris Wong Sing Ee	13D/G 3/4/5	Doris Wong Sing Ee · Chief Executive Officer, Director, 10%+ Owner	21%	1,111,131	$5,555,655	$0	12 Nov 2025	13D/G 3/4/5
Yap Kim Choy	3/4/5 13D/G	10%+ Owner	8.5% from 13D/G	467,535	$2,145,985	—	05 Nov 2025	3/4/5 13D/G
Fitters Diversified Berhad	13D/G 3/4/5	10%+ Owner	8%	279,248	$1,281,748	-$1,039,681	21 Oct 2025	13D/G 3/4/5
Kua Khai Loon	3/4/5	10%+ Owner	8.5%	467,535	$2,145,985	-$814,654	05 Nov 2025	3/4/5
Ong Yee Lung	3/4/5	10%+ Owner	8.5%	467,535	$2,145,985	-$814,758	05 Nov 2025	3/4/5
Kiu Cu Seng	3/4/5	Chief Financial Officer, Director	3.6%	200,000	$280,000	—	12 Nov 2025	3/4/5
TWO SIGMA SECURITIES, LLC	13F	Company	0.51%	27,984	$41,416	—	31 Dec 2025	13F
DRW Securities, LLC	13F	Company	0.45%	24,857	$36,788	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.41%	22,600	$33,448	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.05%	3,007	$4,450	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.01%	584	$864	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2	$3	—	31 Dec 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	2	$3	—	31 Dec 2025	13F
Archer Investment Corp	13F	Company	0%	1	$1	—	31 Dec 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1	$1	—	31 Dec 2025	13F
David E. Lazar	3/4/5	10%+ Owner	— mixed-class rows	510,576 mixed-class rows	$49,868	—	30 Jul 2025	3/4/5
David Natan	3/4/5	Director	— mixed-class rows	800,000 mixed-class rows	$331,500	—	26 Feb 2025	3/4/5
Spiro George Rombotis	3/4/5	President and CEO, Director	— mixed-class rows	184,728 mixed-class rows	$227,601	—	21 Dec 2023	3/4/5
Kenneth M. Ferguson	3/4/5	Director	— mixed-class rows	87,390 mixed-class rows	$149,016	—	30 Jun 2023	3/4/5
Karin L. Walker	3/4/5	Director	— mixed-class rows	83,040 mixed-class rows	$134,596	—	30 Jun 2023	3/4/5
Sam L. Barker	3/4/5	Director	— mixed-class rows	82,853 mixed-class rows	$133,976	—	30 Jun 2023	3/4/5
Christopher S. Henney	3/4/5	Director	— mixed-class rows	81,853 mixed-class rows	$130,661	—	30 Jun 2023	3/4/5
Robert J. Spiegel	3/4/5	Director	— mixed-class rows	81,853 mixed-class rows	$130,661	—	30 Jun 2023	3/4/5
Paul McBarron	3/4/5	E. VP, Fin, CFO, COO and Secretary, Director	— mixed-class rows	105,464 mixed-class rows	$110,648	—	21 Dec 2023	3/4/5
Lloyd Sems	3/4/5	Director	— mixed-class rows	49,841 mixed-class rows	$60,320	—	14 Jun 2022	3/4/5
Brian Schwartz	3/4/5	Interim Chief Medical Officer, Director	— mixed-class rows	27,705 mixed-class rows	$50,405	—	29 Jan 2024	3/4/5
Gregory T. Hradsky	3/4/5	Director	— mixed-class rows	7,122 mixed-class rows	$7,870	—	15 Jun 2021	3/4/5
VSM Wealth Advisory, LLC	13F	Company	— class O/S missing	1,849	$7,376	—	31 Dec 2025	13F
Avraham Ben-Tzvi	3/4/5	Director	— class O/S missing	700,000	—	—	26 Feb 2025	3/4/5
Ho Jien Shiung	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Ho Kee Wee	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Sukses Engineering Sdn Bhd Suria	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Tan Kok Hui	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Mark Kirschbaum	3/4/5	Chief Medical Officer	— class O/S missing	70,200	—	—	30 Jun 2023	3/4/5

Institutional Holders of Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS) as of Q1 2026

As of 31 Mar 2026, Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 118,543 shares. The largest 9 holders included RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, SBI Securities Co., Ltd., OSAIC HOLDINGS, INC., and Archer Investment Corp. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.